ACP
HIMS icon

Arcus Capital Partners’s Hims & Hers Health HIMS Stock Holding History

Arcus Capital Partners’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,365
Closed -$15.2K – 212
2022
Q4 		$15.2K Buy
+2,365
New +$13.5K 0.01% 240

Other funds holding HIMS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
IVMX
Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return
RM
Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return
NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arcus Capital Partners's HIMS Position: Q1 2023 in Review

Arcus Capital Partners sold out of Hims & Hers Health (HIMS) in Q1 2023, closing a stake of 2,365 shares — an estimated $15.2K sold.

Arcus Capital Partners first reported a position in HIMS in Q4 2022 and held it in 1 quarter. The position peaked at $15.2K in Q4 2022. 189 funds tracked by Wall St. Rank hold HIMS as of Q1 2023.

  • Arcus Capital Partners reported no remaining Hims & Hers Health position as of Q1 2023 after selling out during the quarter.
  • Arcus Capital Partners sold 2,365 Hims & Hers Health shares in Q1 2023, an estimated $15.2K.
  • Arcus Capital Partners first reported a position in Hims & Hers Health in Q4 2022 and held it in 1 quarter.
  • Arcus Capital Partners's Hims & Hers Health position peaked at $15.2K in Q4 2022.
  • 189 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.